Push launch MHRA approves GLP –one receptor agonist semaglutide to lessen risk of great heart difficulties in obese or overweight Grown ups Semaglutide is the primary weightloss drug authorised in the united kingdom as being a preventative treatment method for people with recognized cardiovasc